Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Chaguturu Sreekanth K

2. Date of Event Requiring Statement (MM/DD/YYYY) 5/11/2022

3. Issuer Name and Ticker or Trading Symbol

CVS HEALTH Corp [CVS]

(Last) (First) (Middle)

ONE CVS DRIVE

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___X___ Officer (give title below) _____ Other (specify below)
EVP and Chief Medical Officer /

(Street)

WOONSOCKET, RI 02895

(City) (State) (Zip)

5. If Amendment, Date Original Filed(MM/DD/YYYY)

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock (RSU) ⁽¹⁾	996	I	RSU
Common Stock (RSU) ⁽²⁾	354	I	RSU
Common Stock (RSU) ⁽³⁾	2154	I	RSU
Common Stock (RSU) ⁽⁴⁾	1258	I	RSU
Common Stock (RSU) ⁽⁵⁾	2085	I	RSU
Common Stock (RSU) ⁽⁶⁾	2776	I	RSU
Common Stock (RSU) ⁽⁷⁾	6182	I	RSU
Common Stock	2342.7803	D

*Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)*
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Option	11/29/2020 ⁽⁸⁾	11/29/2029	Common Stock	5952	$75.27	I	Option
Stock Option	4/1/2021 ⁽⁹⁾	4/1/2030	Common Stock	9579	$58.34	I	Option
Stock Option	4/1/2022 ⁽¹⁰⁾	4/1/2031	Common Stock	9502	$74.30	I	Option
Stock Option	4/1/2023 ⁽¹¹⁾	4/1/2032	Common Stock	12993	$101.09	I	Option

Explanation of Responses:
(1)	Consists of Restricted Stock Units (RSUs) awarded pursuant to the Issuer's 2017 Stock Incentive Plan. Restrictions lapse on the third anniversary of the grant date.
(2)	Consists of remaining RSUs awarded pursuant to the Issuer's Performance-Based Restricted Stock Plan, a sub-plan under its 2017 Stock Incentive Plan. Restrictions on remaining RSUs lapse on 2/28/2023.
(3)	Consists of remaining RSUs awarded pursuant to the Issuer's 2017 Stock Incentive Plan. Restrictions on the remaining RSUs lapse in two equal installments beginning 4/1/2023.
(4)	Consists of remaining RSUs awarded pursuant to the Issuer's 2017 Stock Incentive Plan. Restrictions on the remaining RSUs lapse in two equal installments beginning 4/1/2023.
(5)	Consists of remaining RSUs awarded pursuant to the Issuer's Performance-Based Restricted Stock Plan, a sub-plan under its 2017 Stock Incentive Plan. Restrictions on remaining RSUs lapse in two equal installments beginning 2/26/2023.
(6)	Consists of RSUs awarded pursuant to the Issuer's 2017 Stock Incentive Plan. Restrictions on remaining RSUs lapse in three equal installments beginning 4/1/2023.
(7)	Consists of remaining RSUs awarded pursuant to the Issuer's 2017 Stock Incentive Plan. Restrictions lapse in four equal installments beginning 4/1/2023.
(8)	Option becomes exercisable in four equal annual installments, commencing 11/29/2020.
(9)	Option becomes exercisable in four equal annual installments, commencing 4/1/2021.
(10)	Option becomes exercisable in four equal annual installments, commencing 4/1/2022.
(11)	Option becomes exercisable in four equal annual installments, commencing 4/1/2023.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Chaguturu Sreekanth K ONE CVS DRIVE WOONSOCKET, RI 02895			EVP and Chief Medical Officer

Signatures
/s/ Sreekanth K. Chaguturu		5/19/2022
^**Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.